- Home
- ANPA vs NRXP Comparison
ANPA vs NRXP Comparison
Compare ANPA & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANPA | NRXP |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | Hong Kong | United States |
| Employees | 32 | 29 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.7M | 99.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ANPA | NRXP |
|---|---|---|
| Price | $7.09 | $3.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.25 |
| AVG Volume (30 Days) | 34.0K | ★ 1.2M |
| Earning Date | 02-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,547.84 |
| Revenue Next Year | N/A | $1,591.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.80 | $1.65 |
| 52 Week High | $180.64 | $3.84 |
Technical Indicators
Market Signals| Indicator | ANPA | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 59.92 |
| Support Level | $5.39 | $2.81 |
| Resistance Level | $10.99 | $3.29 |
| Average True Range (ATR) | 0.93 | 0.22 |
| MACD | 0.28 | -0.01 |
| Stochastic Oscillator | 28.43 | 50.66 |
Price Performance
Historical ComparisonAbout ANPA Rich Sparkle Holdings Limited Ordinary Shares
Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.